NEW ORLEANS, May 26, 2015 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until July 21, 2015 to file lead plaintiff applications in a securities class action lawsuit against IsoRay, Inc. (NYSE MKT:ISR) if they purchased the Company’s securities between May 20, 2015 and May 21, 2015, inclusive (the “Class Period”). This action is pending in the United States District Court for the Central District of California.
What You May Do
If you purchased shares of IsoRay and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, call toll-free at 1-877-515-1850 or email KSF Managing Partner Lewis Kahn (lewis.kahn@ksfcounsel.com). If you wish to serve as a lead plaintiff in this class action, you must petition the Court by July 21, 2015.
About the Lawsuit
IsoRay and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
On May 21, 2015, TheStreet.com published an article claiming that some of IsoRay’s promotional press releases “take liberties with clinical data using clever, selective editing.” In particular, the article stated that the Company’s recent press releases regarding the publication of a study concerning its Celsium-131 product was misleading.
On this news, the price of IsoRay’s shares plummeted by over 35%.
About Kahn Swick & Foti, LLC
To learn more about KSF, whose partners include the Former Louisiana Attorney General, Charles C. Foti, Jr., and other lawyers with significant experience litigating complex securities class actions nationwide on behalf of both institutional and individual shareholders, you may visit www.ksfcounsel.com.